We conducted a mass spectrometry (MS) analysis of PRMT5-binding proteins to explore the molecular pathway through which PRMT5 suppresses ferroptosis in renal cancer cells (Fig. S2M). The gene discussed is PRMT5; the disease is renal carcinoma.